Crossmark

Preclinical and clinical evidence of xanthine oxidase inhibitors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s43066-025-00465-5

Published Online: 2025-10-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alvianto, Steven

Gotama, Yovita

Hengky, Antoninus

Widjanarko, Nicolas Daniel

Stefanus, Mario
License Information

Text and Data Mining valid from 2025-10-15

Version of Record valid from 2025-10-15
More Information

Article History

Received: 9 December 2024

Accepted: 28 September 2025

First Online: 15 October 2025

Declarations

:

: Not applicable as this study did not involve human participants or laboratory animals.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below